Carcinogenesis Advance Access originally published online on August 11, 2006
Carcinogenesis 2007 28(1):136-142; doi:10.1093/carcin/bgl147
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett's oesophagus
Swansea School of Medicine, Swansea University Swansea SA28PP, UK
1 Department of Pharmacy, Ankara University Ankara, Turkey
*To whom correspondence should be addressed. Tel: +017 9229 5361; Fax: +017 9229 5447 Email: g.j.jenkins{at}swansea.ac.uk
Bile acids are often refluxed into the lower oesophagus and are candidate carcinogens in the development of oesophageal adenocarcinoma. We show here that the secondary bile acid, deoxycholic acid (DCA), is the only one of the commonly refluxed bile acids tested here, to show genotoxicity, in terms of chromosome damage and mutation induction in the human p53 gene. This genotoxicity was apparent at both neutral and acidic pH, whilst there was a considerable increase in bile-induced toxicity at acidic pH. The higher levels of cell death and low cell survival rates at acidic pH may imply that acid bile exposure is toxic rather than carcinogenic, as dead cells do not seed cancer development. We also show that DCA (at neutral and acid pH) induced the release of reactive oxygen species (ROS) within the cytoplasm of exposed cells. We further demonstrate that the genotoxicity of DCA is ROS mediated, as micronucleus induction was significantly reduced when cells were treated with DCA + the anti-oxidant vitamin C. In conclusion, we show that DCA, is an effective genotoxin at both neutral and acidic pH. As bile acids like DCA can induce DNA damage at neutral pH, suppressing the acidity of the refluxate will not completely remove its carcinogenic potential. The genotoxicity of DCA is however, ROS dependent, hence anti-oxidant supplementation, in addition to acid suppression may block DCA driven carcinogenesis in Barrett's patients.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. J. S. Jenkins, J. Cronin, A. Alhamdani, N. Rawat, F. D'Souza, T. Thomas, Z. Eltahir, A. P. Griffiths, and J. N. Baxter The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-{kappa}B activation in oesophageal cells, with a mechanism of action involving ROS Mutagenesis, September 1, 2008; 23(5): 399 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Feagins, H. Y. Zhang, X. Zhang, K. Hormi-Carver, T. Thomas, L. S. Terada, S. J. Spechler, and R. F. Souza Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G411 - G417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Zhang, X. Zhang, K. Hormi-Carver, L. A. Feagins, S. J. Spechler, and R. F. Souza In Non-neoplastic Barrett's Epithelial Cells, Acid Exerts Early Antiproliferative Effects through Activation of the Chk2 Pathway Cancer Res., September 15, 2007; 67(18): 8580 - 8587. [Abstract] [Full Text] [PDF]
|
|